Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells
出版年份 2023 全文链接
标题
Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells
作者
关键词
-
出版物
Cell and Bioscience
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-04-11
DOI
10.1186/s13578-023-01015-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate
- (2021) Fan-En Kong et al. Science Translational Medicine
- One-Two Punch Therapy for the Treatment of T-Cell Malignancies Involving p53-Dependent Cellular Senescence
- (2021) Yingjie Qing et al. Oxidative Medicine and Cellular Longevity
- Internalization of Foldamer-Based DNA Mimics through a Site-Specific Antibody Conjugate to Target HER2-Positive Cancer Cells
- (2021) Valentina Corvaglia et al. Pharmaceuticals
- LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan
- (2021) Elham Fakhr et al. BIOMEDICINE & PHARMACOTHERAPY
- Dual intra- and extracellular release of monomethyl auristatin E from a neutrophil elastase-sensitive antibody-drug conjugate
- (2021) Imene Ait Mohamed Amar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Les immunoconjugués en oncologie
- (2020) Alain Beck et al. M S-MEDECINE SCIENCES
- The p38 Pathway: From Biology to Cancer Therapy
- (2020) Adrián Martínez-Limón et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antibody–Drug Conjugates: The Last Decade
- (2020) Nicolas Joubert et al. Pharmaceuticals
- A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancer
- (2020) Feng Chi et al. Translational Oncology
- Inhibition of Ataxia-Telangiectasia Mutated and RAD3-related (ATR) overcomes oxaliplatin resistance and promotes anti-tumor immunity in colorectal cancer.
- (2019) Eve Combes et al. CANCER RESEARCH
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers
- (2019) Yves Lecarpentier et al. Frontiers in Oncology
- Decrease in paracellular permeability and chemosensitivity to doxorubicin by claudin-1 in spheroid culture models of human lung adenocarcinoma A549 cells
- (2018) Risa Akizuki et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Impact of cathepsin B-sensitive triggers and hydrophilic linkers on in vitro efficacy of novel site-specific antibody–drug conjugates
- (2018) Francesca Bryden et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Two-Step Senescence-Focused Cancer Therapies
- (2018) Cynthia J. Sieben et al. TRENDS IN CELL BIOLOGY
- Taking advantage of drug resistance, a new approach in the war on cancer
- (2018) Liqin Wang et al. Frontiers of Medicine
- Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment
- (2018) Diego Tosi et al. BMC CANCER
- Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness
- (2017) Young-Kyoung Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibody targeting of claudin-1 as a potential colorectal cancer therapy
- (2017) S. Cherradi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
- (2017) Prabhsimranjot Singh et al. Journal of Hematology & Oncology
- CLDN6 enhances chemoresistance to ADM via AF-6/ERKs pathway in TNBC cell line MDAMB231
- (2017) Minlan Yang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- CLDN1 Increases Drug Resistance of Non-Small Cell Lung Cancer by Activating Autophagy via Up-Regulation of ULK1 Phosphorylation
- (2017) Zhenhuan Zhao et al. MEDICAL SCIENCE MONITOR
- Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads
- (2016) Takashi Nakada et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway
- (2016) XUEFANG WU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Mechanisms of drug resistance in colon cancer and its therapeutic strategies
- (2016) Tao Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Genetics, diagnosis and management of colorectal cancer (Review)
- (2015) MARINA DE ROSA et al. ONCOLOGY REPORTS
- Bridging Disulfides for Stable and Defined Antibody Drug Conjugates
- (2014) George Badescu et al. BIOCONJUGATE CHEMISTRY
- Drug resistance to targeted therapies: Déjà vu all over again
- (2014) Floris H. Groenendijk et al. Molecular Oncology
- Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling
- (2013) Jillian L Pope et al. GUT
- Cleavage of GSK-3β by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK-3β activity induced by H2O2
- (2013) Ye Feng et al. JOURNAL OF NEUROCHEMISTRY
- GADD45 Proteins: Central Players in Tumorigenesis
- (2012) R. E. Tamura et al. CURRENT MOLECULAR MEDICINE
- Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer
- (2012) Jianbiao Zhou et al. MITOCHONDRION
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
- (2012) Sandra Misale et al. NATURE
- Anti-apoptotic effect of claudin-1 in tamoxifen-treated human breast cancer MCF-7 cells
- (2010) Harue Akasaka et al. BMC CANCER
- Altered expression of cell proliferation-related and interferon-stimulated genes in colon cancer cells resistant to SN38
- (2010) Céline Gongora et al. CANCER BIOLOGY & THERAPY
- Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma
- (2010) S. Paillas et al. CANCER RESEARCH
- High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma
- (2010) Chul Jung Kim et al. EUROPEAN JOURNAL OF CANCER
- GSK3: a multifaceted kinase in Wnt signaling
- (2009) Dianqing Wu et al. TRENDS IN BIOCHEMICAL SCIENCES
- p38 mitogen-activated protein kinase regulates canonical Wnt- -catenin signaling by inactivation of GSK3
- (2008) R. K. Bikkavilli et al. JOURNAL OF CELL SCIENCE
- Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases
- (2008) Dan G. Blazer et al. JOURNAL OF CLINICAL ONCOLOGY
- Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3 Inactivation
- (2008) T. M. Thornton et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started